Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by unplugged1on Jan 14, 2024 7:40am
82 Views
Post# 35825687

RE:RE:Tick-Tock DEA

RE:RE:Tick-Tock DEA The findings required for each of the schedules 1-3 are as follows:
(1)Schedule I.—
(A)
The drug or other substance has a high potential for abuse.
(B)
The drug or other substance has no currently accepted medical use in treatment in the United States.
(C)
There is a lack of accepted safety for use of the drug or other substance under medical supervision.
(2)Schedule II.—
(A)
The drug or other substance has a high potential for abuse.
(B)
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
(C)
Abuse of the drug or other substances may lead to severe psychological or physical dependence.
(3)Schedule III.—
(A)
The drug or other substance has a potential for abuse less than the drugsor other substances in schedules I and II.
(B)
The drug or other substance has a currently accepted medical use in treatment in the United States.
(C)
Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
 

<< Previous
Bullboard Posts
Next >>